Characterisation of the endocannabinoid system in rat haemochorial placenta

Reproductive Toxicology

Volumn 34, Issue 3, 2012, Pages 347-356

  Fonseca, Bruno M ^a,b   Correia da Silva, Georgina ^a,b   Taylor, Anthony H ^c   Lam, Patricia M W ^c   Marczylo, Timothy H ^c   Konje, Justin C ^c   Teixeira, Natércia A ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Cannabinoid receptor; Endocannabinoid system; Giant cells; Placenta; Trophoblast

Indexed keywords

2 ARACHIDONOGLYCEROL; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; ENDOCANNABINOID; ETHANOLAMINE DERIVATIVE; N ACETYLETHANOLAMINE DERIVATIVE; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME METABOLISM; FEMALE; GENETIC TRANSCRIPTION; GIANT CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; MOLECULAR DYNAMICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PLACENTA DEVELOPMENT; PREGNANCY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SYNCYTIOTROPHOBLAST; TROPHOBLAST;

ANIMALS; CYCLOOXYGENASE 2; ENDOCANNABINOIDS; FEMALE; PLACENTA; PLACENTATION; PREGNANCY; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; TRPV CATION CHANNELS;

CANNABIS; RATTUS;

EID: 84865557288     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2012.05.036     Document Type: Article

References (50)

1. De Petrocellis L., Cascio M.G., Di Marzo V. The endocannabinoid system: a general view and latest additions. British Journal of Pharmacology 2004, 141(March (5)):765-774.
2. Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., et al. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochemical and Biophysical Research Communications 1995, 215(October (1)):89-97.
3. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258(December (5090)):1946-1949.
4. Lambert D.M., Di Marzo V. The palmitoylethanolamide and oleamide enigmas: are these two fatty acid amides cannabimimetic?. Current Medicinal Chemistry 1999, 6(August (8)):757-773.
5. Di Marzo V. Endocannabinoids: synthesis and degradation. Reviews of Physiology, Biochemistry and Pharmacology 2008, 160:1-24.
6. Oddi S., Fezza F., Pasquariello N., De Simone C., Rapino C., Dainese E., et al. Evidence for the intracellular accumulation of anandamide in adiposomes. Cellular and Molecular Life Sciences 2008, 65(March (5)):840-850.
7. Oddi S., Fezza F., Pasquariello N., D'Agostino A., Catanzaro G., De Simone C., et al. Molecular identification of albumin and Hsp70 as cytosolic anandamide-binding proteins. Chemistry & Biology 2009, 16(June (6)):624-632.
8. Maccarrone M., Dainese E., Oddi S. Intracellular trafficking of anandamide: new concepts for signaling. Trends in Biochemical Sciences 2010, 35(November (11)):601-608.
9. Kozak K.R., Prusakiewicz J.J., Marnett L.J. Oxidative metabolism of endocannabinoids by COX-2. Current Pharmaceutical Design 2004, 10(6):659-667.
10. Cravatt B.F., Blankman J.L., Simon G.M. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chemistry & Biology 2007, 14(December (12)):1347-1356.
11. Brown A.J. Novel cannabinoid receptors. British Journal of Pharmacology 2007, 152(November (5)):567-575.
12. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346(August (6284)):561-564.
13. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365(September (6441)):61-65.
14. Fonseca B.M., Correia-da-Silva G., Taylor A.H., Konje J.C., Bell S.C., Teixeira N.A. Spatio-temporal expression patterns of anandamide-binding receptors in rat implantation sites: evidence for a role of the endocannabinoid system during the period of placental development. Reproductive Biology and Endocrinology 2009, 7(October (1)):121.
15. Suarez J., Bermudez-Silva F.J., Mackie K., Ledent C., Zimmer A., Cravatt B.F., et al. Immunohistochemical description of the endogenous cannabinoid system in the rat cerebellum and functionally related nuclei. The Journal of Comparative Neurology 2008, 509(August (4)):400-421.
16. Howlett A.C. The cannabinoid receptors. Prostaglandins Other Lipid Mediators 2002, 68/69(August):619-631.
17. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997, 389(October (6653)):816-824.
18. Zygmunt P.M., Petersson J., Andersson D.A., Chuang H., Sorgard M., Di Marzo V., et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 1999, 400(July (6743)):452-457.
19. Park B., McPartland J.M., Glass M. Cannabis, cannabinoids and reproduction. Prostaglandins Leukot Essent Fatty Acids 2004, 70(February (2)):189-197.
20. Paria B.C., Das S.K., Dey S.K. The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling. Proceedings of the National Academy of Sciences of the United States of America 1995, 92(October (21)):9460-9464.
21. Schmid P.C., Paria B.C., Krebsbach R.J., Schmid H.H., Dey S.K. Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation. Proceedings of the National Academy of Sciences of the United States of America 1997, 94(April (8)):4188-4192.
22. Liu W.M., Duan E.K., Cao Y.J. Effects of anandamide on embryo implantation in the mouse. Life Sciences 2002, 71(August (14)):1623-1632.
23. Leiser R., Kaufmann P. Placental structure: in a comparative aspect. Experimental and Clinical Endocrinology 1994, 102(3):122-134.
24. Fonseca B.M., Correia-da-Silva G., Taylor A.H., Lam P.M., Marczylo T.H., Konje J.C., et al. N-acylethanolamine levels and expression of their metabolizing enzymes during pregnancy. Endocrinology 2010, 151(August (8)):3965-3974.
25. Fonseca B.M., Teixeira N.A., Almada M., Taylor A.H., Konje J.C., Correia-da-Silva G. Modulation of the novel cannabinoid receptor - GPR55 - during rat fetoplacental development. Placenta 2011, 32(June (6)):462-469.
26. Stevenson S., Taylor A.H., Meskiri A., Sharpe D.T., Thornton M.J. Differing responses of human follicular and nonfollicular scalp cells in an in vitro wound healing assay: effects of estrogen on vascular endothelial growth factor secretion. Wound Repair and Regeneration 2008, 16(March-April (2)):243-253.
27. Fonseca B.M., Correia-da-Silva G., Taylor A.H., Lam P.M., Marczylo T.H., Bell S.C., et al. The endocannabinoid 2-arachidonoylglycerol (2-AG) and metabolizing enzymes during rat fetoplacental development: a role in uterine remodelling. The International Journal of Biochemistry & Cell Biology 2010, 42(November (11)):1884-1892.
28. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25(December (4)):402-408.
29. Lam P.M., Marczylo T.H., El-Talatini M., Finney M., Nallendran V., Taylor A.H., et al. Ultra performance liquid chromatography tandem mass spectrometry method for the measurement of anandamide in human plasma. Analytical Biochemistry 2008, 380(September (2)):195-201.
30. Marczylo T.H., Lam P.M., Nallendran V., Taylor A.H., Konje J.C. A solid-phase method for the extraction and measurement of anandamide from multiple human biomatrices. Analytical Biochemistry 2009, 384(January (1)):106-113.
31. Kingsley P.J., Marnett L.J. Analysis of endocannabinoids by Ag+ coordination tandem mass spectrometry. Analytical Biochemistry 2003, 314(March (1)):8-15.
32. Trabucco E., Acone G., Marenna A., Pierantoni R., Cacciola G., Chioccarelli T., et al. Endocannabinoid system in first trimester placenta: low FAAH and high CB1 expression characterize spontaneous miscarriage. Placenta 2009, 30(June (6)):516-522.
33. Habayeb O.M., Taylor A.H., Bell S.C., Taylor D.J., Konje J.C. Expression of the endocannabinoid system in human first trimester placenta and its role in trophoblast proliferation. Endocrinology 2008, 149(October (10)):5052-5060.
34. Schuel H. Tuning the oviduct to the anandamide tone. Journal of Clinical Investigation 2006, 116(August (8)):2087-2090.
35. Fonseca B.M., Correia-da-Silva G., Teixeira N.A. Anandamide-induced cell death: dual effects in primary rat decidual cell cultures. Placenta 2009, 30(August (8)):686-692.
36. Schneider M. Cannabis use in pregnancy and early life and its consequences: animal models. European Archives of Psychiatry and Clinical Neuroscience 2009, 259(October (7)):383-393.
37. Khare M., Taylor A.H., Konje J.C., Bell S.C. Delta9-tetrahydrocannabinol inhibits cytotrophoblast cell proliferation and modulates gene transcription. Molecular Human Reproduction 2006, 12(May (5)):321-333.
38. Sun X., Xie H., Yang J., Wang H., Bradshaw H.B., Dey S.K. Endocannabinoid signaling directs differentiation of trophoblast cell lineages and placentation. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(September (39)):16887-16892.
39. Cella M., Leguizamon G.F., Sordelli M.S., Cervini M., Guadagnoli T., Ribeiro M.L., et al. Dual effect of anandamide on rat placenta nitric oxide synthesis. Placenta 2008, 29(August (8)):699-707.
40. Fowler C.J. The contribution of cyclooxygenase-2 to endocannabinoid metabolism and action. British Journal of Pharmacology 2007, 152(November (5)):594-601.
41. Wang H., Xie H., Sun X., Kingsley P.J., Marnett L.J., Cravatt B.F., et al. Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation. Prostaglandins and Other Lipid Mediators 2007, 83(February (1-2)):62-74.
42. Wang H., Matsumoto H., Guo Y., Paria B.C., Roberts R.L., Differential Dey S.K. G protein-coupled cannabinoid receptor signaling by anandamide directs blastocyst activation for implantation. Proceedings of the National Academy of Sciences of the United States of America 2003, 100(December (25)):14914-14919.
43. Smith S.C., Baker P.N., Symonds E.M. Increased placental apoptosis in intrauterine growth restriction. American Journal of Obstetrics and Gynecology 1997, 177(December (6)):1395-1401.
44. Huestis M.A. Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol and cannabinol. Handbook of Experimental Pharmacology 2005, (168):657-690.
45. Cintado C.G., Pinto F.M., Devillier P., Merida A., Candenas M.L. Increase in neurokinin B expression and in tachykinin NK(3) receptor-mediated response and expression in the rat uterus with age. Journal of Pharmacology and Experimental Therapeutics 2001, 299(December (3)):934-938.
46. Porcella A., Casellas P., Gessa G.L., Pani L. Cannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body: implications for the antiglaucoma properties of marihuana. Molecular Brain Research. 1998, 58(July (1-2)):240-245.
47. Dvorakova M., Kummer W. Transient expression of vanilloid receptor subtype 1 in rat cardiomyocytes during development. Histochemistry and Cell Biology 2001, 116(September (3)):223-225.
48. Porcella A., Marchese G., Casu M.A., Rocchitta A., Lai M.L., Gessa G.L., et al. Evidence for functional CB1 cannabinoid receptor expressed in the rat thyroid. Eur J Endocrinol 2002, 147(August (2)):255-261.
49. Rebsamen M.C., Perrier E., Gerber-Wicht C., Benitah J.P., Lang U. Direct and indirect effects of aldosterone on cyclooxygenase-2 and interleukin-6 expression in rat cardiac cells in culture and after myocardial infarction. Endocrinology 2004, 145(July (7)):3135-3142.
50. Duncan M., Thomas A.D., Cluny N.L., Patel A., Patel K.D., Lutz B., et al. Distribution and function of monoacylglycerol lipase in the gastrointestinal tract. American Journal of Physiology - Gastrointestinal & Liver Physiology. 2008, 295(December (6)):G1255-G1265.